AUSTAR is a technology-based pharmaceutical engineering solution provider with a deep understanding of industry regulations and processes. The company integrates global high-quality resources to help clients improve process and operational effectiveness.

Austar Lifesciences Limited

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.

6118

HK:COM:AUSTAR

AUSTAR

Last Close

0.61

25/11 06:12

Market Cap

312.68M

Beta: -

Volume Today

264K

Avg: -

name

homepage url

country

employee count

sector

industry

revenue

monthly webtraffic

monthly webtraffic growth

Description

competitor of

Metrics